The neuropsychiatry of chronic cocaine abuse

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 10, Issue 3, 1998, Pages 280-289

  Bolla, Karen I ^a   Cadet, Jean Lud ^b   London, Edythe D ^b  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ARTICLE; BEHAVIOR; BRAIN FUNCTION; CINGULATE GYRUS; DECISION MAKING; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; NEUROCHEMISTRY; NEUROPSYCHIATRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL;

EID: 0031872816     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.10.3.280     Document Type: Article

References (82)

1. Peterson RC: Cocaine: an overview, in NIDA Research Monograph 13, edited by Stillman RC, Peterson RC. Washington, DC, DHEW, 1977, pp 17-34
2. Barnes DM: Drugs: running the numbers. Science 1988; 240:1729-1731
3. Cadet JL, Bolla KI: Chronic cocaine use as a neuropsychiatric syndrome: a model for debate. Synapse 1996; 22:28-34
4. Mirenowicz J, Schultz W: Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 1996; 379:449-451
5. Kuhar MJ, Pilotte NS: Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 1996; 7:260-264
6. Wilson JM, Levey AI, Bergeron C, et al: Striatal dopamine, dopamine transporter and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 1996; 40:428-439
7. Hitri A, Casanova MF, Kleinman JE, et al: Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. Am J Psychiatry 1994; 151:1074-1076
8. London ED, Wilkerson G, Goldberg SR, et al: Effects of 1-cocaine on local cerebral glucose utilization in the rat. Neurosci Lett 1986; 68:73-78
9. Porrino LJ, Domer FR, Crane AM, et al: Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacologia 1988; 1:109-118
10. Lyons D, Friedman DP, Nader MA, et al: Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci 1996; 16:1230-1238
11. 2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14:169-177
12. Mayberg HS, Starkstein SE, Sadzot B, et al: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990; 28:57-64
13. Biegon A, Dillon KA, Volkow ND, et al: Quantitative autoradiography of cocaine binding sites in human brain postmortem. Synapse 1992; 10:126-130
14. Dackis CA, Gold MS: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neuroscience and Biobehavior Review 1985; 9:469
15. Volkow ND, Mullani H, Gould KL, et al: Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry 1988; 152:641-648
16. Teoh SK, Mendelson JG, Woods BT, et al: Pituitary volume in men with concurrent heroin and cocaine dependence. J Clin Endocrinol Metab 1993; 76:1529-1532
17. Volkow ND, Fowler JS, Wolf AP, et al: Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148:621-626
18. Volkow ND, Fowler JS: Brain-imaging studies of the combined use of cocaine and alcohol and of the pharmacokinetics of cocaethylene. NIDA Research Monograph 1994; 138:41-56
19. Tella SR, Landenheim B, Andrews AM, et al: Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J Neurosci 1996; 16:7416-7427
20. Roy CW, Sherrington CS: On the regulation of the blood supply of the brain. J Physiol (Lond) 1980; 11:85-108
21. Nilsson B, Rehncrona S, Siesjo BK: Coupling of cerebral metabolism and blood flow in epileptic seizures, hypoxia, and hypoglycaemia. Ciba Found Symp 1978; 56:199-218
22. Des Rosiers MH, Kennedy C, Patlak CS, et al: Relationship between local cerebral blood flow and glucose utilization in the rat. Neurology 1974; 24:389
23. Raichle ME, Grubb R, Gado MH, et al: Correlation between regional cerebral blood flow and oxidative mechanisms. Arch Neurol 1976; 33:523-526
24. Ingvar DH, Lassen NA: Activity distribution in the cerebral cortex in organic dementia as revealed by measurements of regional cerebral blood flow, in Brain Function in Old Age, edited by Hochmeister F, Muller C. New York, Springer-Verlag, 1979, pp 268-277
25. 2. Am J Med 1953; 15:171-174
26. Porrino LJ: Functional effects of cocaine depend upon route of administration. Psychopharmacology 1993; 112:343-351
27. London ED, Cascella NG, Wong DF, et al: Cocaine induced reduction of glucose utilization in human brain. Arch Gen Psychiatry 1990; 47:567-574
28. Pearlson GD, Jeffery PJ, Harris GJ, et al: Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am J Psychiatry 1993; 150:495-197
29. Volkow ND, Hitzemann R, Wang GJ, et al: Long-term frontal metabolic changes in cocaine abusers. Synapse 1992; 11:184-190
30. Stapleton JM, Morgan MJ, Phillips RL, et al: Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology 1995; 13:21-31
31. Mena I, Miller B, Garrett K, et al: Neurospect in cocaine abuse (abstract). Eur J Nucl Med 1990; 16:53137
32. Tumeh SS, Nagel SJ, English RJ, et al: Use of SPECT perfusion brain scintigraphy to investigate effects of cocaine on the brain, in Physiopathology of Illicit Drugs: Cannabis, Cocaine Opiates, edited by Nahas GG, Latour G. Oxford, UK, Pergamon Press, 1991, pp 143-151
33. Strickland TL, Mena I, Villanueva-Meyer J, et al: Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1993; 5:419-427
34. Sloan MA, Mattioni TA: Concurrent myocardial and cerebral infarctions after intranasal cocaine use. Stroke 1992; 23:427-430
35. Klonoff DC, Andrews BT, Obana WG: Stroke associated with cocaine use. Arch Neurol 1989; 46:989-993
36. Levine SR, Brust JCM, Futrell N, et al: Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 1990; 323:699-704
37. Levine SR, Brust JCM, Futrell N, et al: A comparative study of the cerebrovascular complications of cocaine: alkoloidal versus hydrochloride. A review. Neurology 1991; 41:1173-1177
38. Daras M, Tuchman AJ, Marks S: Central nervous system infarction related to cocaine abuse. Stroke 1991; 22:1320-1325
39. Powers RH, Madden JA: Vasoconstrictive effects of cocaine metabolites, and structural analogs on cat cerebral arteries (abstract). FASEB J 1990; 4:A1095
40. Isner JM, Chokshi SK: Cocaine and vasospasm. N Engl J Med 1989; 321:1604-1606
41. Rumbaugh C, Bergeron T, Scanlan R, et al: Cerebral vascular changes secondary to amphetamine abuse in the experimental animal. Radiology 1971; 101:345-351
42. Hardebo JE, Edvinson L, Owman C, et al: Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels: possible implications in migraine. Neurology 1978; 28:64-70
43. Mody CK, Miller BL, McIntyre HB, et al: Neurologic complications of cocaine abuse. Neurology 1988; 38:1189-1193
44. Rowley HA, Lowenstein DH, Rowbotham MC, et al: Thalamomesencephalic strokes after cocaine abuse. Neurology 1989; 39:428-130
45. Levine SR, Welch KMA: Cocaine and stroke. Stroke 1988; 19:779-783
46. Pascual-Leone A, Dhuna A, Anderson DC: Cerebral atrophy in habitual cocaine abusers: a planimetric CT study. Neurology 1991; 41:34-38
47. Langendorf FG, Anderson DC, Tupper DE, et al: Brain atrophy and chronic cocaine abuse: background and work in progress. Rockville, MD, U.S. Dept. of Health and Human Services, National Institutes of Health. National Institute on Drug Abuse Research Monograph Series: Neurotoxicity and Neuropathology Associated with Cocaine Abuse, 1996
48. Cascella NG, Pearlson G, Wong DF, et al: Effects of substance abuse on ventricular and sulcal measures assessed by computerized tomography. Br J Psychiatry 1991; 159:217-221
49. Liu X, Phillips RL, Resnick SM, et al: Magnetic resonance imaging reveals no ventriculomegaly in polydrug abusers. Acta Neurol Scand 1995; 92:83-90
50. Berry J, Van Gorp WG, Herzberg DS, et al: Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 1993; 32:231-237
51. Meek PS, Clark HW, Solana VL: Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment. J Psychoactive Drugs 1989; 21:153-160
52. Manschreck TC, Schneyer ML, Weisstein CC, et al: Freebase cocaine and memory. Compr Psychiatry 1990; 31:369-375
53. Ardila A, Rosselli M, Strumwasser S: Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991; 57:73-79
54. Hoff AL, Riordan H, Alpert R, et al: Cognitive function in chronic cocaine abusers (abstract). J Clin Exp Neuropsychol 1991; 13:60
55. Mittenburg W, Motta S: Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol 1993; 8:477-483
56. Weber DA, Klieger P, Volkow ND, et al: SPECT regional cerebral blood flow (rCBF) studies in crack users and control participants. J Nucl Med 1990; 31:876-877
57. Stuss DT, Benson DF: The Frontal Lobes. New York, Raven, 1986
58. Ohnishi T, Hoshi H, Nagamachi S, et al: High resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995; 36:1163-1169
59. Lezak MD: Neuropsychological Assessment, 3rd edition. New York, Oxford University Press, 1995
60. Wide RJ, Bernardi S, Frackowiak R, et al: Serial observation on the pathophysiology of acute stroke: the transition from ischemia to infarction as reflected in regional oxygen extraction. Brain 1983; 106:197-222
61. Gawin FH, Kleber HD: Abstinence symptomatology and psychiatric diagnoses in cocaine abusers: clinical observations. Arch Gen Psychiatry 1986; 43:107-113
62. Stein DJ, Hollander E, Cohen L: Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Res 1993; 48:257-266
63. Bauer LO, O'Connor S, Hesselbrock VM: Frontal P300 decrements in antisocial personality disorder. Alcohol Clin Exp Res 1994: 18:1300-1305
64. Bechara A, Damasio AR, Damasio H, et al: Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50:7-15
65. Rolls ET, Baylis LL: Gustatory, olfactory, and visual convergence within the primate orbitofrontal cortex. J Neurosci 1994; 14:5437-5452
66. Rolls ET, Burton MJ, Mora F: Neurophysiological analysis of brain-stimulation reward in the monkey. Brain Research 1980; 194:339-357
67. Mora F, Avrith DB, Rolls ET: An electrophysiological and behavioral study of self-stimulation in the orbitofrontal cortex of the rhesus monkey. Brain Res Bull 1980; 5:111-115
68. Grant S, London ED, Newlin DB, et al: Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 1996; 93:12040-12045
69. Baxter LRJ, Phelps ME, Mazziotta JC, et al: Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987; 44:211-218
70. Benkelfat C, Nordahl TE, Semple WE, et al: Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 1990; 47:840-848
71. Dworkin SI, Smith JE: Cortical regulation of self-administration in Neurobiology of Drug and Alcohol Addiction, edited by Kalivas PW, Samson HA. New York, New York Academy of Sciences, 1992, pp 274-281
72. Paus T, Petrides M, Evans A, et al: Role of human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: a positron emission tomography study. J Neurophysiol 1993; 70:453-469
73. Johanson CE, Fischman MW: The pharmacology of cocaine related to its abuse. Pharmacol Rev 1989; 41:3-52
74. Wang GJ, Volkow ND, Roque CT, et al: Functional importance of ventricular enlargement and cortical atrophy in healthy participants and alcoholics as assessed with PET, MR imaging, and neuropsychological testing. Radiology 1993; 186:59-65
75. Bolla KI, Schwartz BS, Stewart W, et al: A comparison of neurobehavioral function in workers exposed to a mixture of organic and inorganic lead and in workers exposed to solvents. Am J Ind Med 1995; 27:231-246
76. Bleecker ML, Bolla I, Agnew J, et al: Dose-related subclinical neurobehavioral effects of chronic exposure to low levels of organic solvents. Am J Ind Med 1991; 19:715-728
77. Cadet JL, Landenheim B, Hiroshi H, et al: Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 1995; 21:169-176
78. Dolan RJ, Friston KJ: Positron emission tomography in psychiatric and neuropsychiatric disorders. Semin Neurol 1989; 9:330-337
79. Petersen SE, Fox BT, Posner MI, et al: Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature 1988; 331:585-589
80. Grasby PM, Friston KJ, Bench CJ, et al: The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task: measuring neuromodulatory effects of psychotropic drugs in man. Eur J Neurosci 1992; 4:1203-1212
81. Squire LR, Ojemann JG, Miezin FM, et al: Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci USA 1992; 89:1837-1841
82. Weinberger DR, Berman KF, Zee RF: Physiologic dysfunction of the dorsolateral prefrontal cortex in schizophrenia: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43:114-124